Nassim Usman, Catalyst Biosciences CEO
After $60M Vertex deal, group of Catalyst shareholders claims biotech could’ve sold assets three years ago
Catalyst Biosciences was down to five employees in March, and the biotech needed to do something after two rounds of layoffs, a nixed collaboration and …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.